Estate Planners Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-181
Closed -$5.24K 104
2025
Q4
$5.24K Buy
+181
New +$5.43K ﹤0.01% 333

Other funds holding ARKG

Estate Planners Group's ARKG Position: Q1 2026 in Review

Estate Planners Group sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 181 shares — an estimated $5.24K sold.

Estate Planners Group first reported a position in ARKG in Q4 2025 and held it in 1 quarter. The position peaked at $5.24K in Q4 2025. 219 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Estate Planners Group reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Estate Planners Group sold 181 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $5.24K.
  • Estate Planners Group first reported a position in ARK Genomic Revolution ETF in Q4 2025 and held it in 1 quarter.
  • Estate Planners Group's ARK Genomic Revolution ETF position peaked at $5.24K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Estate Planners Group's 13F filing for Q1 2026, filed 11 May 2026.